The Israeli biopharmaceutical company will focus on developing drugs to treat schizophrenia and Alzheimer’s psychosis. Read More Start ups    | Read More Israel Insider | NOWlej  | Read More in Virtual Jerusalem.   Read More in Israel NOWlej.